AMED:NSD-Amedisys, Inc (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 232.91

Change

+0.53 (+0.23)%

Market Cap

USD 7.54B

Volume

0.14M

Average Target Price

USD 245.94 (+5.59%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including heart disease, pulmonary disease, Alzheimer's, or cancer. The Personal Care segment provides assistance for patients with the activities of daily living. As of February 18, 2020, the company owned and operated 479 care centers in 38 states and the District of Columbia. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana. Address: 3854 American Way, Baton Rouge, LA, United States, 70816

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-09-28 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LHCG LHC Group, Inc

+4.62 (+2.28%)

USD6.41B 51.75 25.44
ENSG The Ensign Group, Inc

+0.56 (+1.00%)

USD3.01B 23.15 16.08
ACHC Acadia Healthcare Company, Inc

-0.22 (-0.78%)

USD2.51B 22.97 12.66
HCSG Healthcare Services Group, Inc

-0.16 (-0.76%)

USD1.58B 19.71 11.57
ADUS Addus HomeCare Corporation

+0.52 (+0.56%)

USD1.47B 43.21 23.98
PRSC The Providence Service Corpora..

+2.90 (+3.36%)

USD1.22B 293.50 15.65
PNTG The Pennant Group, Inc

-0.11 (-0.30%)

USD1.04B 199.14 86.34
SGRY Surgery Partners, Inc

+0.42 (+2.16%)

USD0.99B 63.00 12.88
TVTY Tivity Health, Inc

+0.26 (+1.89%)

USD0.67B 8.78 N/A
AMEH Apollo Medical Holdings, Inc

+0.67 (+3.97%)

USD0.61B 27.93 3.63

ETFs Containing AMED

Symbol Name Weight Mer Price(Change) Market Cap
EWMC Invesco S&P MidCap 400 Eq.. 0.00 % 0.40 %

+1.43 (+2.44%)

USD0.07B
XHS SPDR S&P Health Care Serv.. 0.00 % 0.35 %

+1.03 (+1.39%)

USD0.08B
XRSU:LSE Xtrackers Russell 2000 UC.. 0.00 % 0.30 %

+7.34 (+3.56%)

USD0.65B
R2US:LSE SPDR Russell 2000 US Smal.. 0.00 % 0.30 %

+1.26 (+3.12%)

USD0.50B
AGES:LSE iShares Ageing Population.. 0.00 % 0.40 %

+7.10 (+1.58%)

USD0.28B
VRTIX Vanguard Russell 2000 Ind.. 0.00 % 0.08 %

+5.45 (+2.41%)

USD2.43B
VRTGX Vanguard Russell 2000 Gro.. 0.00 % 0.08 %

+5.62 (+1.87%)

USD0.87B
OLD The Long-Term Care ETF 0.00 % 0.30 %

+0.36 (+1.44%)

USD0.02B
VTWO Vanguard Russell 2000 Ind.. 0.00 % 0.10 %

+3.05 (+2.58%)

USD2.43B
JKK iShares Morningstar Small.. 0.00 % 0.30 %

+4.85 (+2.10%)

USD0.22B
VTWG Vanguard Russell 2000 Gro.. 0.00 % 0.15 %

+2.89 (+1.83%)

USD0.87B
TZA Direxion Daily Small Cap .. 0.00 % 1.07 %

-1.38 (-7.57%)

USD0.63B
TWM ProShares UltraShort Russ.. 0.00 % 0.95 %

-0.47 (-4.97%)

USD0.13B
SRTY ProShares UltraPro Short .. 0.00 % 0.95 %

-0.70 (-7.58%)

USD0.18B
SMLF iShares MSCI USA Small-Ca.. 0.00 % 0.30 %

+0.91 (+2.50%)

USD0.57B
RWM ProShares Short Russell20.. 0.00 % 0.95 %

-0.84 (-2.42%)

USD0.51B
PTH Invesco DWA Healthcare Mo.. 0.00 % 0.60 %

+0.64 (+0.48%)

USD0.52B
2B77:XETRA iShares Ageing Population.. 0.00 % 0.40 %

+0.11 (+2.27%)

USD0.28B

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 39.53% 88% B+ 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.53% 88% B+ 83% B
Trailing 12 Months  
Capital Gain 77.78% 86% B 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 77.78% 86% B 87% B+
Trailing 5 Years  
Capital Gain 513.41% 100% A+ 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 513.41% 100% A+ 95% A
Average Annual (5 Year Horizon)  
Capital Gain 47.29% N/A N/A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 47.29% N/A N/A 91% A-
Risk Return Profile  
Volatility (Standard Deviation) 41.48% N/A N/A 30% F
Risk Adjusted Return 114.00% N/A N/A 95% A
Market Capitalization 7.54B 100% A+ 91% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 58.18 40% F 19% F
Price/Book Ratio 10.12 31% F 12% F
Price / Cash Flow Ratio 37.35 31% F 8% F
EV/EBITDA 31.44 23% F 22% F
Management Effectiveness  
Return on Equity 20.15% 88% B+ 91% A-
Return on Invested Capital 19.70% 94% A 91% A-
Return on Assets 7.89% 88% B+ 93% A
Debt to Equity Ratio 36.26% 50% F 51% F
Technical Ratios  
Short Ratio 3.62 50% F 45% F
Short Percent 2.24% 73% C 59% F
Beta 0.89 50% F 65% D
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Higly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector